Vanda Pharmaceuticals Inc. et al v. Roxane Laboratories Inc. 1:13-cv-01973;
Filed: 11/25/2013; Case Updated Daily; Latest Docket Entry: 07/07/2016; PACER
5 days ago ... Two of Vanda Pharmaceutical's patents for its schizophrenia drug Fanapt are
valid, and Roxane Laboratories Inc. violated one of them when attempting to
make a generic, a Delaware ... Vanda Pharmaceuticals Inc. et al v.
3 days ago ... Vanda Pharmaceuticals fends off patent challenge from generic competitor ...
Ohio-based generics maker Roxane Laboratories Inc. sought ...
5 days ago ... Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc. 1:16-cv-00465; filed
June 20, 2016 in the District Court of Delaware. Infringement ...
Mar 20, 2016 ... Roxane Laboratories Inc. 1:15-cv-00919; filed October 13, 2015 in the District
Court of Delaware. Vanda Pharmaceuticals Inc. v. Inventia ...
Nov 10, 2015 ... tent, sued Roxane Laboratories, Inc. (“Roxane”) and Cipla,. Ltd. (“Cipla”) (
together .... factures the active pharmaceutical ingredient, alosetron.
Jan 6, 2016 ... Vanda Pharmaceuticals Inc. v. Roxane Laboratories, Inc., C.A. No. 13-1973-GMS
(consol.) (D. Del. Dec. 30, 2015). Judge Sleet denied the ...
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Vanda
Pharmaceuticals Inc., et al. v. Roxane Laboratories, Inc., Civil Action No.
Jun 10, 2016 ... In the post-trial opinion in Genzyme Corporation, et al. v. Dr. Reddy's
Laboratories, et al., C.A. No. .... Judge Gregory M. Sleet recently considered
defendant Roxane Laboratories, Inc.'s letter ... Vanda Pharmaceuticals Inc. v.
Sep 22, 2015 ... Original Assignee, Vanda Pharmaceuticals, Inc. .... a pharmaceutical composition
comprising at least one of iloperidone, ...... Opposition to Roxane's Motion to
Dismiss, Vanda Pharmaceuticals Inc. v. .... 47, Memorandum of Defendant
Roxane Laboratories, Inc. In Support of Its Motion to Dismiss, C.A. No.